Clinical trial
The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of…
NCT00162877 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00162877 |
|---|---|
| Title | The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships |
| Official title | The Role of CYP2C19 Poor Metabolizers and Extensive Metabolizers of PPI in Short-Term Triple Therapy on the Eradication of H. Pylori Infection: Implication of PK/PD Relationships |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection |
| Intervention type | Drug |
| Interventions | Rabeprazole vs. Esomeprazole |
| Enrollment | 80 |
| Start date | Jun 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Sep 13, 2005 |
| Last update posted | Nov 23, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: